Norges Bank’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-449,400
Closed -$3.47M 1305
2024
Q4
$3.47M Buy
+449,400
New +$3.47M ﹤0.01% 1589
2024
Q3
Sell
-147,546
Closed -$1.73M 1369
2024
Q2
$1.73M Sell
147,546
-72,978
-33% -$854K ﹤0.01% 1744
2024
Q1
$4.65M Hold
220,524
﹤0.01% 1635
2023
Q4
$3.96M Sell
220,524
-50,418
-19% -$905K ﹤0.01% 1716
2023
Q3
$4.46M Hold
270,942
﹤0.01% 1701
2023
Q2
$5.42M Hold
270,942
﹤0.01% 1700
2023
Q1
$5.12M Sell
270,942
-55,676
-17% -$1.05M ﹤0.01% 1745
2022
Q4
$7.41M Hold
326,618
﹤0.01% 1654
2022
Q3
$8.63M Hold
326,618
﹤0.01% 1593
2022
Q2
$8.07M Sell
326,618
-21,761
-6% -$537K ﹤0.01% 1640
2022
Q1
$11.6M Hold
348,379
﹤0.01% 1650
2021
Q4
$11.4M Buy
348,379
+27,849
+9% +$911K ﹤0.01% 1722
2021
Q3
$13.4M Buy
320,530
+6,967
+2% +$292K ﹤0.01% 1663
2021
Q2
$12.2M Sell
313,563
-25,572
-8% -$993K ﹤0.01% 1719
2021
Q1
$11.6M Buy
339,135
+4,278
+1% +$146K ﹤0.01% 1754
2020
Q4
$15.2M Buy
334,857
+5,992
+2% +$272K ﹤0.01% 1650
2020
Q3
$9.05M Sell
328,865
-26,513
-7% -$730K ﹤0.01% 1740
2020
Q2
$13.1M Sell
355,378
-16,932
-5% -$624K ﹤0.01% 1640
2020
Q1
$12.1M Hold
372,310
﹤0.01% 1529
2019
Q4
$15.3M Hold
372,310
﹤0.01% 1665
2019
Q3
$13.3M Buy
372,310
+37,041
+11% +$1.32M ﹤0.01% 1675
2019
Q2
$17.2M Buy
335,269
+18,846
+6% +$968K 0.01% 1586
2019
Q1
$18.1M Buy
316,423
+59,024
+23% +$3.38M 0.01% 1563
2018
Q4
$10.8M Buy
257,399
+39,735
+18% +$1.67M ﹤0.01% 1710
2018
Q3
$16.4M Buy
+217,664
New +$16.4M 0.01% 1622
2017
Q1
Sell
-44,943
Closed -$834K 2174
2016
Q4
$834K Buy
+44,943
New +$834K ﹤0.01% 2078
2016
Q3
Sell
-11,597
Closed -$93K 2166
2016
Q2
$93K Sell
11,597
-6,603
-36% -$53K ﹤0.01% 2167
2016
Q1
$197K Sell
18,200
-1,800
-9% -$19.5K ﹤0.01% 2164
2015
Q4
$332K Hold
20,000
﹤0.01% 2196
2015
Q3
$441K Buy
+20,000
New +$441K ﹤0.01% 2202